Adverse effects of intradermal allogeneic lymphocyte immunotherapy: Acute reactions and role of autoimmunity

Human Reproduction

Volumn 21, Issue 2, 2006, Pages 429-435

  Kling, C ^a   Steinmann, J ^a   Westphal, E ^a   Magez, J ^a   Kabelitz, D ^a  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

Allogeneic lymphocyte immunotherapy; Autoimmunity; Graft versus host disease; HIV; Rhesus haemolytic disease

Indexed keywords

HLA ANTIGEN CLASS 1;

ANAPHYLAXIS; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; BLISTER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DERMIS; DONOR; ERYTHEMA; FEMALE; FOLLOW UP; GRAFT VERSUS HOST REACTION; HLA MATCHING; HOST; HUMAN; HUMAN CELL; IMMUNOTHERAPY; INCIDENCE; INFECTION PREVENTION; INFERTILITY; LYMPHOCYTE TRANSFUSION; MALE; PREGNANCY; PROSPECTIVE STUDY; PRURITUS; QUESTIONNAIRE; RISK ASSESSMENT; SKIN MANIFESTATION; THROMBOEMBOLISM; VACCINATION;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 31544436599     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/dei316     Document Type: Article

References (41)

1. Adams KM and Nelson JL (2004) Microchimerism: An investigative frontier in autoimmunity and transplantation. J Am Med Assoc 291,1127-1131.
2. Beer AE, Quebbeman JF, Ayers JW and Haines RF (1981) Major histocompatibility complex antigens, maternal and paternal immune responses, and chronic habitual abortions in humans. Am J Obstet Gynecol 141,987-999.
3. Centers for Disease Control (1996) Update: Vaccine side effects, adverse reactions, contraindications, and precautions. Recommendations of the Advisory Committee on Immunization Practices (ACID). MMWR Recomm Rep 45,1-35.
4. Center for Biologics Evaluation and Research (2001) Lymphocyte Immune Therapy. www.fda.gov/cber/ltr/lit013002.htm; Access May 22, 2005.
5. Chaouat G (2003) Should we re-examine the status of lymphocyte alloimmunization therapy for recurrent spontaneous abortion? Am J Reprod Immunol 50,433-438.
6. Christiansen OB, Christiansen BS, Husth M, Mathiesen O, Lauritsen JG and Grunnet N (1992) Prospective study of anticardiolipin antibodies in immunized and untreated women with recurrent spontaneous abortions. Fertil Steril 58,328-334.
7. Christiansen OB, Nielsen HS and Pedersen B (2004) Active or passive immunization in unexplained recurrent miscarriage. J Reprod Immunol 62,41-52.
8. Clark DA, Coulam CB, Daya S and Chaouat G (2001) Unexplained sporadic and recurrent miscarrage in the new millennium: A critical analysis of immune mechanisms and treatments. Hum Reprod Update 7,501-511.
9. Clarke JA, Hollinger FB, Lewis E, Russell LA, Miller CH, Huntley A and Flynn NM (1989) Intradermal inoculation with Heptavax-B. Immune response and histologic evaluation of injection sites. J Am Med Assoc 262,2567-2571.
10. Combs MR, Drew MJ, Goodnough LT et al (2002) Brecher ME et al (ed), Technical Manual aaBB. American Association of Blood Banks, Bethesda, Maryland, USA.
11. Cooper GS and Stroehla BC (2003) The epidemiology of autoimmune diseases. Autoimmun Rev 2,119-125.
12. Doherty RA, Stubblefield P, Dostal-Johnson DA and Day GJ (1992) White blood cell immunization and anticardiolipin antibody levels in women with recurrent miscarriages. Fertil Steril 58,199-201.
13. Hentschel R, Broecker EB, Kolde G, Frosch M, Friedrich W, Holzgreve W, Westphal E and Harms E (1995) Intact survival with transfusion-associated graft-versus-host disease proved by human leukocyte antigen typing of lymphocytes in skin biopsy specimens. J Pediatr 126,61-64.
14. Hopkins K (2000) The Basic Lymphocyte Microcytotoxicity Tests: Standard and AHG Enhancement. In Hahn A, Land G and Strothman R (eds) ASHI Laboratory Manual. American Society for Histocompatibility and Immunogenetics, Mt Laurel, NJ, USA, pp I.C.1-1-7.
15. Jacobson DL, Gange SJ, Rose NR and Graham NM (1997) Epidemiology and estimated population burden of selected autoimmune diseases in the United States. Clin Immunol Immunopathol 84,223-243.
16. Karrer S, Holler E and Szeimies RM (2001) [Cutaneous manifestations of graft-versus-host disease]. Med Klin (Munich) 96,457-466.
17. Katz I, Fisch B, Amit S, Ovadia J and Tadir Y (1992) Cutaneous graft-versus-host-like reaction after paternal lymphocyte immunization for prevention of recurrent abortion. Fertil Steril 57,927-929.
18. Kenney RT, Frech SA, Muenz LR, Villar CP and Glenn GM (2004) Dose sparing with intradermal injection of influenza vaccine. New Engl J Med 351,2295-2301.
19. Kilpatrick DC (1992) Cardiolipin antibody levels are not influenced by leukocyte immunotherapy in patients experiencing recurrent spontaneous abortion. Fertil Steril 57,328-330.
20. Kiprov DD, Sheppard HW and Hanson CV (1994) Alloimmunization to prevent AIDS? Science 263,737-738.
21. Kling C, Magez J, Jenisch S and Kabelitz D (2002a) [Effect of allogeneic leukocyte immunization on consecutive IVF/ICSI treatment for failure in the in-vitro fertilization program]. Geburtsh Frauenheilk 62,661-667.
22. Kling C, Magez J, Jenisch S and Kabelitz D (2002b) Experience with allogeneic leukocyte immunization for implantation failure in the in-vitro fertilization program. Am J Reprod Immunol 48,147.
23. Lam GK, Subramanyam L, Orton S, Farb R and Moise KJ Jr (2003) Minimizing red blood cell contamination while isolating mononuclear cells from whole blood: The next step for the treatment of severe hemolytic disease of the fetus/newborn. Am J Obstet Gynecol 189,1012-1016.
24. Lau C and Sisson J (2002) The effectiveness of intradermal pre-exposure rabies vaccination in an Australian travel medicine clinic. J Travel Med 9,285-288.
25. Lindqvist P, Dahlback B and Marsal K (1999) Thrombotic risk during pregnancy: A population study. Obstet Gynecol 94,595-599.
26. McLellan AD, Heiser A, Sorg RV, Fearnley DB and Hart DN (1998) Dermal dendritic cells associated with T lymphocytes in normal human skin display an activated phenotype. J Invest Dermatol 111,841-849.
27. Moncayo R, Moncayo H, Steffens U, Soelder E, Kersting A and Dapunt O (1990) Serum levels of anticardiolipin antibodies are pathologically increased after active immunization of patients with recurrent spontaneous abortion. Fertil Steril 54,619-623.
28. Nelson JL (2001) HLA relationships of pregnancy, microchimerism and autoimmune disease. J Reprod Immunol 52,77-84.
29. Neppert J, Witzleben-Schurholz E, Zupanska B, Bartz L, Greve O, Eichler H, Kerowgan M and Wichmann MG (1999) High incidence of maternal HLA A, B and C antibodies associated with a mild course of haemolytic disease of the newborn. Group for the Study of Protective Maternal HLA Antibodies in the Clinical Course of HDN. Eur J Haematol 63,120-125.
30. Ober C, Karrison T, Odem RR, Barnes RB, Branch DW, Stephenson MD, Baron B, Walker MA, Scott JR and Schreiber JR (1999) Mononuclear-cell immunisation in prevention of recurrent miscarriages: A randomised trial. Lancet 354,365-369.
31. Poulsen LO, Tage-Jensen U, Christiansen OB, Grunnet N and Vyberg M (1994) Autoimmune hepatitis associated with allogeneic lymphocyte immunisation. J Hepatol 21,1149.
32. Prigoshin N, Tambutti ML, Redal MA, Gorgorza S, Lancuba SM, Nicholson R and Testa R (1999) Microchimerism and blocking activity in women with recurrent spontaneous abortion (RSA) after alloimmunization with the partner's lymphocytes. J Reprod Immunol 44,41-54.
33. Quayle AJ, Fidel P, Jr and Rosenberg ES (2004) Sex, alloimmunization, and susceptibility to HIV infection. Lancet 363,503-504.
34. Recurrent Miscarriage Immunotherapy Trialists Group (1994) Worldwide collaborative observational study and meta-analysis on allogenic leukocyte immunotherapy for recurrent spontaneous abortion. Am J Reprod Immunol 32,55-72.
35. Regan L, Braude PR and Hill DP (1991) A prospective study of the incidence, time of appearance and significance of anti-paternal lymphocytotoxic antibodies in human pregnancy. Hum Reprod 6,294-298.
36. Rivey MP and Peterson J (1991) Intradermal hepatitis B vaccination. Drug Intelligence and Clinical Pharmacy (DICP)/Annals of Pharmacotheraphy 25,628-634.
37. Scott JR (2000) Immunotherapy for recurrent miscarriage. Cochrane Database Syst Rev, CD000112.
38. Shearer GM, Pinto LA and Clerici M (1999) Alloimmunization for immune-based therapy and vaccine design against HIV/AIDS. Immunol Today 20,66-71.
39. Taylor C and Faulk WP (1981) Prevention of recurrent abortion with leucocyte transfusions. Lancet 2,68-70.
40. van der Mast BJ, van den Dorpel MA, Drabbels JJ, Claas FH and Weimar W (2003) Transfusion-associated graft versus host disease after donor-specific leukocyte transfusion before kidney transplantation. Clin Transplant 17,477-483.
41. Zhou W, Pool V, Iskander JK, English-Bullard R, Ball R, Wise RP, Haber P, Pless RP, Mootrey G, Ellenberg SS et al (2003) Surveillance for safety after immunization: Vaccine Adverse Event Reporting System (VAERS) - United States, 1991-2001. MMWR Surveill Summ 52,1-24.